Micronuclei and Nuclear Abnormalities Observed in Erythroblasts in Myelodysplastic Syndromes and in de novo Acute Leukemia after Treatment

Publisher： Karger

E-ISSN： 1421-9662|101|1|32-40

ISSN： 0001-5792

Source： Acta Haematologica, Vol.101, Iss.1, 1999-03, pp. : 32-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis, bcl-2 Expression and p53 Accumulation in Myelodysplastic Syndrome, Myelodysplastic-Syndrome-Derived Acute Myelogenous Leukemia and de novo Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 102, Iss. 3, 2004-11 ,pp. : 115-123

Karger

Access to resources Recommend Favorite

Translocation t(11;17) in de novo Myelodysplastic Syndrome Not Associated with Acute Myeloid or Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-11 ,pp. : 48-54

Karger

Access to resources Recommend Favorite

DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes

By  

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite